Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. SciSparc intends to evaluate the efficacy, safety and tolerability of its SCI-110 in a randomized, double-blind, placebo controlled, cross-over study. About SciSparc (OTCQB: SPRCY): SciSparc Ltd.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

Cannabis Chronicles

APRIL 2, 2019

The Food and Drug Administration says the May 31 meeting will discuss the science, safety and sale of cannabis compounds like CBD. It also said any products that make drug or treatment claims also need to be approved by the FDA. The FDA has approved a pharmaceutical version of CBD to treat rare seizure disorders.

CBD 113

CBD Food Pharmaceutical Collective 113

Cannabis Law Report

JUNE 10, 2021

–(BUSINESS WIRE)– CURE Pharmaceutical Holding Corp. We’ve been working to develop safe, accurately-dosed cannabis solutions for several years now and we believe that this collaboration will help us take that initiative to the next level and expand our reach,” said Rob Davidson, CURE Pharmaceutical CEO. OXNARD, Calif.–(BUSINESS

Pharmaceutical 75

Pharmaceutical DEA Research and Development THC 75

Veriheal

AUGUST 12, 2021

Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC. It goes by the name of “artisanal CBD.” .

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Cannabis Law Report

AUGUST 17, 2021

.–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. Chief Medical Officer of Marinus. “We Data Highlights.

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

NORML

FEBRUARY 23, 2020

Update : Hb 1343 is scheduled for a Criminal Justice and Public Safety Committee Executive Session at 1pm on 3/3/20 in Legislative Office Building 204. The bill would allow qualifying patients to access all the alternative treatment centers instead of having to designate just one. NH resident? NH resident? OK resident?

Legislation 255

Legislation Patients Decriminalization Access 255

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. “ Off-label use ” (which is extremely common) is: the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration.

Therapy 107

Therapy Legalization Chronic Pain DEA 107

The Cannigma

MARCH 17, 2021

Some women who chose to use cannabis for postpartum depression say they did so because standard prescription treatments did not help and the side effects from pharmaceutical treatments were intolerable. Furthermore, not seeking treatment means not being able to solve the problem, exacerbating the situation all the more.

Research and Development 143

Research and Development Treatment Sleep Cannabis 143

Cannabis Law Report

AUGUST 5, 2021

Psychedelics are quickly emerging as alternative methods of treatment for mental illnesses and neurodegenerative conditions — particularly in countries such as Canada. Additionally, the technology backed by the patent will be essential for transforming variable psychedelic raw materials into pharmaceutical-grade standardized extracts.

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

Veriheal

MARCH 18, 2021

They needed a model for Alzheimer’s disease in order to effectively review cannabidiol (CBD) as a potential treatment. Unfortunately, both of these conditions result in cognitive decline and suffer from a lack of effective treatment. Why Aging Cats? What Did The Study Find?

CBD 109

CBD Research and Development Pets Treatment 109

Cannabis Law Report

OCTOBER 29, 2021

Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin. Further strengthens the Company’s drug development pipeline of tryptamines by introducing novel psilocin analogues containing enhancements in safety and efficacy tailored for medical use. October 27, 2021. DENVER, Oct.

Pharmaceutical 52

Pharmaceutical Research and Development Data Safety 52

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. Repeat seizures can result in a life-threatening condition called status epilepticus that requires emergency medical treatment. What Does Epidiolex Treat?

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JUNE 2, 2021

and has no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision.” Pharmaceutical Grade CBD Oil. Epidiolex is a Schedule V controlled substance approved for the treatment of seizures. Idaho Code § 37-2701 et seq. Idaho Code § 37-2704.

Law 103

Law Marijuana Oil Pharmaceutical 103

The Cannigma

MARCH 7, 2022

One trial has already made it to Phase II and is actively recruiting, meaning that it passed safety and tolerability studies in healthy patients, and trials in specific individuals are already underway. It is exploring the treatment of pain from osteoarthritis with cannabinoid ratios – specifically, CBD + CBN and CBD + THC versus placebo.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Cannabis Law Report

JUNE 12, 2021

MONTEREY, CA – Biopharmaceutical Research Company (BRC), an active Drug Enforcement Administration (DEA) license holder, and CURE Pharmaceutical Holding Corp. CURE has established itself as a leader in the oral application of cannabis-derived treatments, and we know we’ll be able to bring a lot of value to patients together.”.

DEA 45

DEA Pharmaceutical Research and Development Compliance 45

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Commence clinical program in PTSD.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

Cannabis Law Report

JUNE 16, 2021

“Santé is a key partner to for Wake as they are a leading contract research organization (CRO) in Canada with expertise in advancing plant-based pharmaceutical products through various phases of clinical trial development. ABOUT SANTÉ CANNABIS.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. Unfortunately, the conventional pharmaceuticals used to treat these symptoms have significant side effects leaving families with no solution.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

DECEMBER 3, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Chief Executive Officer of Marinus Pharmaceuticals. “We Chief Executive Officer of Marinus Pharmaceuticals. “We Webcast to be held Monday, December 6 at 1:00 p.m. ET (12:00 p.m. RADNOR, Pa.–(BUSINESS

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

Veriheal

MAY 17, 2021

Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” She ends the column by stating “ I urge our legislators to abandon this legislation for the sake of our citizen’s health and safety.”.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

MMJ Recs

JULY 11, 2024

Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals. In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers.

Sleep 111

Sleep Treatment Research and Development Therapy 111

MMJ Recs

JUNE 26, 2020

Marijuana Use In Safety Sensitive Job Duties In Oklahoma. Safety Sensitive jobs and work duties were detailed. Employers were given the legal right to take MMJ use into account when their employees would be engaged in Safety Sensitive work. What Are Safety Sensitive Jobs In Oklahoma MMJ Law? Dispensing pharmaceuticals.

Marijuana 69

Marijuana Safety Pharmaceutical Patients 69

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. ” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. Over the prior three years or so, 41,260 RYAH-connected patients reported medical cannabis use for the treatment of pain. RYAH Group Inc.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

JULY 24, 2021

This expansive patent would allow Mydecine to scale its coverage in drug development research in lieu of promising discoveries and FDA-approval progress for novel therapeutics, including granting Breakthrough Therapy Designation to MDMA for the treatment of PTSD in recent years. About Mydecine Innovations Group.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

MMJ Recs

NOVEMBER 20, 2023

Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition. Neurological Disorders: Several cannabinoids show promise in the treatment of neurological disorders, including multiple sclerosis (MS) and Parkinson’s disease.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Veriheal

SEPTEMBER 7, 2022

law—specifically, the Legalization of Marijuana for Medical Treatment Initiative of 1999—for a total of 225 days. Those who can afford to sacrifice medical program benefits to consistently access medical cannabis treatment will be fine. The Medical Marijuana Self-Certification Temporary Amendment Act of 2022 currently permits D.C.

Patients 98

Patients Programs Access Treatment 98

Veriheal

FEBRUARY 28, 2022

The need for effective treatment is not only important for restoring one’s health but also for returning functioning and quality of life. Current antidepressants can have some serious side effects, as most pharmaceuticals do. A New Kind of Depression Treatment. In 2019, the U.S.

Research and Development 98

Research and Development Treatment Therapy Environment 98

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Google Translation.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

LifeCannMD

MARCH 3, 2025

At 62, this Miami resident had navigated years of conventional treatment approaches for her persistent neuropathic discomfort. Initially hesitant due to personal perceptions, Elena discovered marijuana THC edibles that transformed her treatment experience.

Edibles 52

Edibles Marijuana Dispensary Patients 52

Cannabis Law Report

AUGUST 16, 2021

The Ridgell case is an appeal of the Department of Child Safety’s decision to keep a former employee of the department on the registry. Compared to the risks of the pharmaceuticals prescribed for HG that weren’t working, or the risk of having untreated HG, which is a one in three chance of a miscarriage? 10 donors.

Safety 116

Safety Patients Cannabis Law 116

Canna Care Docs

OCTOBER 3, 2023

Conventional medication methods such as opiates may help terminal patients focus on more palliative treatment options and goals in order to better one’s comfort and overall quality of life during this time. However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

JANUARY 11, 2023

PRESS RELEASE UK company Chanelle McCoy Health granted Ethics Approval to commence Phase III Efficacy Clinical Trial for the treatment of Sleep Disturbance CMH-CBD-001 using their Ultra Pure Synthetic Cannabinoid (CBD) formulation with pharmaceutical grade FDA registered raw material.

Clinical Trials 52

Clinical Trials CBD Sleep Pharmaceutical 52

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 40

Pharmaceutical Clinical Trials Research and Development Therapy 40

Cannabis Law Report

DECEMBER 28, 2021

–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX) achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are summarized below. “I BERWYN, Pa.–(BUSINESS

Pharmaceutical 40

Pharmaceutical Research and Development Clinical Trials Chronic Pain 40

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. In other cases, CBDA products — or a mixture of CBD and CBDA — may be preferable, if for instance treatments with high doses of CBD have been unsuccessful for you.

CBD 122

CBD Research and Development Epilepsy Extraction 122